Kits Eyecare Ltd.

Kits Eyecare Ltd.

13.07
USD
-0.11
(-0.83%)
0.09EPS
120.71P/E
376.54MMarket Cap
Mar 10Next Earn
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
- -
1.19
2.43
2.74
2.93
3.84
5.06
6.32
6.98
Basic EPS, GAAP
- -
- -
-0.21
-0.49
-0.15
-0.07
0.1
0.1
0.13
Free Cash Flow per Basic Share
- -
0.1
0.13
-0.77
0.14
0.06
0.31
0.35
0.42
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
- -
0.2
-0.02
1.76
1.72
1.64
1.83
1.93
2.19
Tangible Book Value per Share
- -
-1.25
-1.39
0.45
0.38
0.39
0.49
0.68
0.96
Basic Weighted Avg Shares
31
31
31
30
31
31
32
32
33
Sales/Revenue/Turnover
- -
37
75
82
92
121
159
202
233
Operating Margin (%)
- -
5.47
-0.3
-21.55
-7.31
-1.19
1.73
4.08
3.37
Depreciation Expense
- -
1
2
3
4
3
3
2
2
Net Income, GAAP
- -
- -
-7
-15
-5
-2
3
3
4
Effective Tax Rate (%)
- -
41.11
- -
- -
- -
- -
29.99
38.38
36.77
Profit Margin (%)
- -
0.14
-8.75
-17.74
-4.97
-1.84
1.96
1.54
1.87
Working Capital
- -
-23
-24
19
13
9
6
15
25
LT Debt
- -
1
1
19
16
12
6
5
4
Total Equity
- -
6
-1
55
54
51
58
62
74
Return on Invested Capital (%)
- -
7.81
- -
- -
- -
- -
5.5
5.34
7.31
Return on Capital (%)
- -
7.62
- -
- -
- -
- -
5.76
4.74
6.7
Return on Common Equity (%)
- -
1.71
- -
- -
-8.39
-4.21
5.7
5.17
6.4

Capital Structure

CAD

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
1
1
1
LT Borrowings
- -
- -
- -
LT Finance Leases
4
4
4
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
34
34
34
Market Capitalization
497
476
536

Working Capital

CAD

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
56
57
60
Cash, Cash Equivalents & STI
22
27
31
Accounts Receivable, Net
5
3
2
Inventories
27
25
26
Total Current Liabilities
33
32
35
Payables & Accruals
24
24
27
ST Debt
1
1
1
Deferred Revenue
7
7
7

Growth Rates

CAD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-1,929.42%
7.64%
Free Cash Flow
- -
-81.98%
14.62%
Net Income, GAAP
- -
-47.81%
-0.19%
Sales/Revenue/Turnover
- -
22.31%
27.06%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
35
38
42
45
159
2025
47
50
52
54
202
2026
57
58
64
- -
- -

Quarterly Earnings Per Share

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
0.01
- -
0.09
0.1
2025
0.05
-0.02
0.06
0.01
0.1
2026
0.06
0.04
0.02
- -
- -

Quarterly Dividends Per Share

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

CEO
Roger V. Hardy
Full Time Employees
176
Sector
Retail trade
Industry
Internet retail
Address
510 Seymour Street Vancouver BC Canada V6B 3J5
IPO Date
Jan 19, 2021
Website
kits.ca
Business
Kits Eyecare Ltd. (TSX: KITS) operates as a vertically integrated online retailer of eyeglasses and vision care products in Canada. The company manufactures, markets, and sells prescription eyeglasses, non-prescription sunglasses, contact lenses, and related vision care accessories through its e-commerce platform and physical retail locations; it offers a portfolio of owned and licensed brands including its flagship Kits brand, along with private-label options and designer collaborations. Kits Eyecare provides comprehensive services such as virtual try-on technology, in-house optical labs for custom lens production, same-day prescription fulfillment, and eye exam partnerships with licensed optometrists.[ from prior context] Founded in 2018 and headquartered in Vancouver, British Columbia, the company serves the Canadian consumer market with a focus on affordable, high-quality vision care solutions for adults and children. Its operations span online sales nationwide and brick-and-mortar stores in major urban centers across British Columbia, Alberta, and Ontario. Kits Eyecare targets budget-conscious consumers seeking convenience over traditional optical retail, competing in the digital health and e-commerce eyewear segment.[ from prior context] In recent developments, Kits Eyecare completed its initial public offering on the Toronto Stock Exchange in May 2024, raising approximately C$65 million to fuel expansion; the company launched new physical retail formats and expanded its lab capacity in 2024-2025 to support growing demand. It announced strategic partnerships with major lens manufacturers for advanced progressive and blue-light blocking technologies in late 2024. No major acquisitions, rebrands, or funding rounds have been reported in 2025 as of December.

Company News

  • What Kits Eyecare (KITS) Said on Its Q3 Earnings Call

  • Kits Eyecare Ltd. (KITS:CA) Q3 2026 Earnings Call Transcript

  • Kits Eyecare Tops C$250M Run Rate as High-Margin Glasses Sales Surge

  • Kits Eyecare Eyes Glasses-Led Growth as Margins Expand and Capacity Ramps

  • Cedar Grove Capital Q3 2026 Portfolio Update

  • Kits Eyecare Q2 Earnings Call Highlights

  • Kits Eyecare Ltd. (KITS:CA) Q1 2026 Earnings Call Transcript

  • Short Interest in Kits Eyecare Ltd. (OTCMKTS:KTYCF) Rises By 54.6%

  • Kits Eyecare: A Buying Opportunity After The Recent Sell-Off

  • Kits Eyecare Ltd. (KITS:CA) Q4 2025 Earnings Call Transcript

  • Kits Eyecare Ltd. (KITS:CA) Q3 2025 Earnings Call Transcript